{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:23:09Z","timestamp":1790806989708,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science & Technology Department Sichuan Province Foundation of China","award":["2017KZ0044"],"award-info":[{"award-number":["2017KZ0044"]}]},{"name":"Sichuan Medical Law Research Center Foundation of China","award":["YF15-Y03"],"award-info":[{"award-number":["YF15-Y03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3358-5","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T08:16:03Z","timestamp":1531296963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists\u2019 effect on prescribing practice at a tertiary hospital"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2973-5612","authenticated-orcid":false,"given":"Hongli","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingze","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunlin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"5","key":"3358_CR1","doi-asserted-by":"publisher","first-page":"E222","DOI":"10.1503\/cmaj.1095383","volume":"189","author":"P Webster","year":"2017","unstructured":"Webster P. Antibiotic overprescribing a growing problem. CMAJ. 2017;189(5):E222. \n                    https:\/\/doi.org\/10.1503\/cmaj.1095383\n                    \n                  .","journal-title":"CMAJ"},{"issue":"0","key":"3358_CR2","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.5604\/17322693.1222106","volume":"70","author":"M Kazberuk","year":"2016","unstructured":"Kazberuk M, Brzosko S, Hryszko T, Naumnik B. Overuse of proton pump inhibitors and its consequences. Postepy Hig Med Dosw (Online). 2016;70(0):1112\u20136. \n                    https:\/\/doi.org\/10.5604\/17322693.1222106\n                    \n                  .","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"1","key":"3358_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5606\/ehc.2017.00056","volume":"28","author":"OS Atik","year":"2017","unstructured":"Atik OS. Overuse and abuse of cortisone. Eklem Hastalik Cerrahisi. 2017;28(1):1. \n                    https:\/\/doi.org\/10.5606\/ehc.2017.00056\n                    \n                  .","journal-title":"Eklem Hastalik Cerrahisi"},{"issue":"7","key":"3358_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1572-0241.2004.30894.x","volume":"99","author":"NM Guda","year":"2004","unstructured":"Guda NM, Noonan M, Kreiner MJ, Partington S, Vakil N. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? Am J Gastroenterol. 2004;99(7):1233\u20137. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2004.30894.x\n                    \n                  .","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3358_CR5","doi-asserted-by":"publisher","first-page":"e56060","DOI":"10.1371\/journal.pone.0056060","volume":"8","author":"SR Rotman","year":"2013","unstructured":"Rotman SR, Bishop TF. Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009. PLoS One. 2013;8(2):e56060. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0056060\n                    \n                  .","journal-title":"PLoS One"},{"issue":"4","key":"3358_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/157488410793352067","volume":"5","author":"E Ramirez","year":"2010","unstructured":"Ramirez E, Lei SH, Borobia AM, Pinana E, Fudio S, Munoz R, et al. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol. 2010;5(4):288\u201397.","journal-title":"Curr Clin Pharmacol"},{"issue":"12","key":"3358_CR7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1046\/j.1365-2036.2003.01600.x","volume":"17","author":"F Parente","year":"2003","unstructured":"Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003;17(12):1503\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3358_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11096-006-9028-4","volume":"28","author":"K Grant","year":"2006","unstructured":"Grant K, Al-Adhami N, Tordoff J, Livesey J, Barbezat G, Reith D. Continuation of proton pump inhibitors from hospital to community. Pharm World Sci. 2006;28(4):189\u201393. \n                    https:\/\/doi.org\/10.1007\/s11096-006-9028-4\n                    \n                  .","journal-title":"Pharm World Sci"},{"issue":"11","key":"3358_CR9","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1111\/j.1572-0241.2000.03259.x.","volume":"95","author":"RJ Nardino","year":"2000","unstructured":"Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95(11):3118\u201322. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2000.03259.x.","journal-title":"Am J Gastroenterol"},{"issue":"7634","key":"3358_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","volume":"336","author":"I Forgacs","year":"2008","unstructured":"Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2\u20133. \n                    https:\/\/doi.org\/10.1136\/bmj.39406.449456.BE\n                    \n                  .","journal-title":"BMJ"},{"issue":"6","key":"3358_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/MOG.0b013e328358d5b9","volume":"28","author":"NS Abraham","year":"2012","unstructured":"Abraham NS. Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol. 2012;28(6):615\u201320. \n                    https:\/\/doi.org\/10.1097\/MOG.0b013e328358d5b9\n                    \n                  .","journal-title":"Curr Opin Gastroenterol"},{"issue":"06","key":"3358_CR12","first-page":"372","volume":"12","author":"HL LUO","year":"2015","unstructured":"LUO HL, XIAO SL, WEI QM. Investigation and analysis of the use of proton pump inhibitors in inpatients. Chinese J Drug Appl Monitor. 2015;12(06):372\u20135.","journal-title":"Chinese J Drug Appl Monitor"},{"issue":"24","key":"3358_CR13","first-page":"3212","volume":"43","author":"ZL XU","year":"2014","unstructured":"XU ZL, LI YC, XIANG P. Investigate the use of PPI to stress ulcer prophylaxis in 1745 cases of surgical patients receiving aseptic-contaminative and contaminative incision operation. Chongqing. Medicine. 2014;43(24):3212\u20136.","journal-title":"Medicine"},{"issue":"08","key":"3358_CR14","first-page":"135","volume":"14","author":"JC TANG","year":"2017","unstructured":"TANG JC. Investigation and analysis of clinical application of proton pump inhibitors in surgical patients of our hospital. China Med Herald. 2017;14(08):135\u20138.","journal-title":"China Med Herald"},{"issue":"1","key":"3358_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5662\/wjm.v1.i1.15","volume":"1","author":"CS Eom","year":"2011","unstructured":"Eom CS, Lee SS. Risk of fracture and pneumonia from acid suppressive drugs. World J Methodol. 2011;1(1):15\u201321. \n                    https:\/\/doi.org\/10.5662\/wjm.v1.i1.15\n                    \n                  .","journal-title":"World J Methodol"},{"issue":"29","key":"3358_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001227","volume":"94","author":"SW Ho","year":"2015","unstructured":"Ho SW, Hsieh MJ, Yang SF, Yeh YT, Wang YH, Yeh CB. Risk of stroke-associated pneumonia with acid-suppressive drugs: a population-based cohort study. Medicine (Baltimore). 2015;94(29):e1227. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000001227\n                    \n                  .","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"3358_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ajg.2012.394","volume":"108","author":"S Chandra","year":"2013","unstructured":"Chandra S, Agarwal D, Surana A. Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation. Am J Gastroenterol. 2013;108(2):277\u20138. \n                    https:\/\/doi.org\/10.1038\/ajg.2012.394\n                    \n                  .","journal-title":"Am J Gastroenterol"},{"key":"3358_CR18","doi-asserted-by":"publisher","unstructured":"Niu Q, Wang Z, Zhang Y, Wang J, Zhang P, Wang C, et al. Combination use of Clopidogrel and proton pump inhibitors increases major adverse cardiovascular events in patients with coronary artery disease: a meta-analysis. J Cardiovasc Pharmacol Ther. 2016; \n                    https:\/\/doi.org\/10.1177\/1074248416663647\n                    \n                  .","DOI":"10.1177\/1074248416663647"},{"issue":"2","key":"3358_CR19","doi-asserted-by":"publisher","first-page":"e88971","DOI":"10.1371\/journal.pone.0088971","volume":"9","author":"HX Zhang","year":"2014","unstructured":"Zhang HX, Li X, Huo HQ, Liang P, Zhang JP, Ge WH. Pharmacist interventions for prophylactic antibiotic use in urological inpatients undergoing clean or clean-contaminated operations in a Chinese hospital. PLoS One. 2014;9(2):e88971. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0088971\n                    \n                  .","journal-title":"PLoS One"},{"issue":"04","key":"3358_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.12010\/j.issn.1673-5846.2016.04.013","volume":"11","author":"HH Liu","year":"2016","unstructured":"Liu HH, Liao GP. The analysis of proton pump inhibitor use after clinical pharmacists intervention. China J Pharmaceut Econ. 2016;11(04):39\u201340. \n                    https:\/\/doi.org\/10.12010\/j.issn.1673-5846.2016.04.013\n                    \n                  .","journal-title":"China J Pharmaceut Econ"},{"issue":"5","key":"3358_CR21","doi-asserted-by":"publisher","first-page":"e0155020","DOI":"10.1371\/journal.pone.0155020","volume":"11","author":"ZK Ye","year":"2016","unstructured":"Ye ZK, Liu Y, Cui XL, Liu LH. Critical appraisal of the quality of clinical practice guidelines for stress ulcer prophylaxis. PLoS One. 2016;11(5):e0155020. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0155020\n                    \n                  .","journal-title":"PLoS One"},{"issue":"10","key":"3358_CR22","doi-asserted-by":"publisher","first-page":"e0186302","DOI":"10.1371\/journal.pone.0186302","volume":"12","author":"H Luo","year":"2017","unstructured":"Luo H, Fan Q, Xiao S, Chen K. Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations. PLoS One. 2017;12(10):e0186302. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0186302\n                    \n                  .","journal-title":"PLoS One"},{"issue":"32","key":"3358_CR23","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3969\/j.issn.1671-8348.2012.32.040.","volume":"41","author":"HLYY Luo","year":"2012","unstructured":"Luo HLYY, Wang SR, Xiao SL, Liu D. The analysis of prophylactic antibiotic use in perioperative period before and after antibiotic special campaign. Chongqing Med. 2012;41(32):3448\u201350. \n                    https:\/\/doi.org\/10.3969\/j.issn.1671-8348.2012.32.040.","journal-title":"Chongqing Med"},{"issue":"2","key":"3358_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2753.2012.01838.x","volume":"19","author":"C Bez","year":"2013","unstructured":"Bez C, Perrottet N, Zingg T, Leung Ki EL, Demartines N, Pannatier A. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. J Eval Clin Pract. 2013;19(2):374\u20138. \n                    https:\/\/doi.org\/10.1111\/j.1365-2753.2012.01838.x\n                    \n                  .","journal-title":"J Eval Clin Pract"},{"issue":"5","key":"3358_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1365-2753.2006.00742.x","volume":"13","author":"KO Hwang","year":"2007","unstructured":"Hwang KO, Kolarov S, Cheng L, Griffith RA. Stress ulcer prophylaxis for non-critically ill patients on a teaching service. J Eval Clin Pract. 2007;13(5):716\u201321. \n                    https:\/\/doi.org\/10.1111\/j.1365-2753.2006.00742.x\n                    \n                  .","journal-title":"J Eval Clin Pract"},{"issue":"11","key":"3358_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/SMJ.0b013e3181f6539d","volume":"103","author":"S Hussain","year":"2010","unstructured":"Hussain S, Stefan M, Visintainer P, Rothberg M. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients? South Med J. 2010;103(11):1103\u201310. \n                    https:\/\/doi.org\/10.1097\/SMJ.0b013e3181f6539d\n                    \n                  .","journal-title":"South Med J"},{"issue":"3","key":"3358_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10620-012-2423-x","volume":"58","author":"CP Koczka","year":"2013","unstructured":"Koczka CP, Geraldino-Pardilla LB, Goodman AJ. Physicians\u2019 opinions of stress ulcer prophylaxis: survey results from a large urban medical center. Dig Dis Sci. 2013;58(3):777\u201381. \n                    https:\/\/doi.org\/10.1007\/s10620-012-2423-x\n                    \n                  .","journal-title":"Dig Dis Sci"},{"issue":"16","key":"3358_CR28","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3748\/wjg.v19.i16.2560","volume":"19","author":"JS Ahn","year":"2013","unstructured":"Ahn JS, Eom CS, Jeon CY, Park SM. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013;19(16):2560\u20138. \n                    https:\/\/doi.org\/10.3748\/wjg.v19.i16.2560\n                    \n                  .","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3358_CR29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajhp\/56.4.347","volume":"56","author":"ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis","year":"1999","unstructured":"ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP commission on therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm. 1999;56(4):347\u201379.","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"3358_CR30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jacc.2011.12.024","volume":"59","author":"AL Frelinger 3rd","year":"2012","unstructured":"Frelinger AL 3rd, Lee RD, Mulford DJ, Wu J, Nudurupati S, Nigam A, et al. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. J Am Coll Cardiol. 2012;59(14):1304\u201311. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.12.024\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3358_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jacc.2009.12.071","volume":"56","author":"JS Hulot","year":"2010","unstructured":"Hulot JS, Collet JP, Silvain J, Pena A, Bellemain-Appaix A, Barthelemy O, et al. Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration. a systematic meta-analysis J Am Coll Cardiol. 2010;56(2):134\u201343. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2009.12.071\n                    \n                  .","journal-title":"a systematic meta-analysis J Am Coll Cardiol"},{"key":"3358_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0638-6","volume":"15","author":"W Zeng","year":"2015","unstructured":"Zeng W, Finlayson AE, Shankar S, de Bruyn W, Godman B. Prescribing efficiency of proton pump inhibitors in China: influence and future directions. BMC Health Serv Res. 2015;15:11. \n                    https:\/\/doi.org\/10.1186\/s12913-014-0638-6\n                    \n                  .","journal-title":"BMC Health Serv Res"},{"key":"3358_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-183","volume":"13","author":"Y Tang","year":"2013","unstructured":"Tang Y, Zhang X, Yang C, Yang L, Wang H, Zhang X. Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China. BMC Health Serv Res. 2013;13:183. \n                    https:\/\/doi.org\/10.1186\/1472-6963-13-183\n                    \n                  .","journal-title":"BMC Health Serv Res"},{"issue":"Suppl 2","key":"3358_CR34","first-page":"S18","volume":"5","author":"D Armstrong","year":"2005","unstructured":"Armstrong D. Intravenous proton pump inhibitor therapy: a rationale for use. Rev Gastroenterol Disord. 2005;5(Suppl 2):S18\u201330.","journal-title":"Rev Gastroenterol Disord"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3358-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3358-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3358-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T19:11:30Z","timestamp":1562785890000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3358-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3358"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3358-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data collected in our study were obtained all necessary administrative permissions to access and subsequently use.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"537"}}